Hong Kong Baptist University (HKBU), the first institution funded by the University Grants Committee (UGC) to offer undergraduate education in Chinese medicine and pharmacy in Chinese medicine in Hong Kong, established the School of Chinese Medicine (SCM) in 1999. SCM is committed to providing quality academic programmes, conducting cutting-edge research and technology development, offering first-rate Chinese medicine healthcare service, and contributing to the standardisation, modernisation and internationalisation of Chinese medicine. SCM is proud to have achieved a leading position in Chinese medicine in the higher education sector in Hong Kong.
With our quality teaching staff and following the whole person education ethos of the University, SCM provides quality Chinese medicine programmes to nurture new generations of Chinese medicine professionals and scientists and advance the development of Chinese medicine in Hong Kong and beyond. The School offers a wide range of academic programmes leading to the award of different academic qualifications, including UGC-funded undergraduate and research postgraduate programmes as well as self-financed taught master's, diploma and certificate programmes.
We offer two undergraduate programmes, the Bachelor of Chinese Medicine and Bachelor of Science (Hons) in Biomedical Science double degree programme and the Bachelor of Pharmacy (Hons) in Chinese Medicine programme launched in 1998 and 2001 respectively. HKBU is the first institution provided with funding by UGC to offer these two programmes and until now no other local universities offer the same programmes. We have produced outstanding graduates, who have established their careers in healthcare, scientific research, teaching, medical management and trading in Chinese medicines in Hong Kong and other parts of the world. There are also alumni engaged in postgraduate studies in biomedical science, Chinese medicine or pharmacy in Chinese medicine.
SCM has identified three strategic research focuses, viz. precision medicine and phenomics study, translational medicine and innovative drug discovery, and authentication and testing of Chinese medicines. Our academics are engaged in studies on the causes and methods of treating different kinds of diseases by integrating Chinese medicine theories and clinical experiences with new technologies of different scientific disciplines.
We have established eight research centres, namely "Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research", "Institute for Advancing Translational Medicine in Bone and Joint Diseases", "Hong Kong Chinese Medicine Clinical Study Centre", "Mr. & Mrs. Ko Chi Ming Centre for Parkinson's Disease Research", "Consun Chinese Medicines Research Centre for Renal Diseases", "Research Centre for Standardization of Chinese Medicines", "Institute of Integrated Bioinformedicine and Translational Science" and "Institute for Precision Medicine and Innovative Drug". Apart from our state-of-the-art research facilities in the SCM Building on campus, we have also set up research bases in the Hong Kong Science Park, Hong Kong Baptist University Institute of Research and Continuing Education in Shenzhen, Hong Kong Baptist University Changshu Research Institute, and Hong Kong Baptist University (Haimen) Institute of Science and Technology.
SCM has made remarkable achievements in scientific research in recent years. In addition to winning a large number of research grants from HKBU, the HKSAR Government and the mainland Government, our experts publish frequently in academic journals with high impact factor. The School has also made considerable progress in terms of the number of patent applications filed and patents granted. All in all, it has attained a leading position in the field of Chinese medicine research in Hong Kong.
The School has been proactive in seeking collaborations with enterprises and set up the "University－Enterprise Synergy Innovation Platform", the purpose of which is to optimise the use of talents and resources of SCM and the partner organisations. The Platform conducts joint research and seeks to realise the industrialisation of research findings so as to promote innovative Chinese medicine research and foster the development of Chinese medicine pharmaceutical industry.
SCM established the Hong Kong Chinese Medicine Authentication Centre to provide services for quality assurance, authentication and safety testing of Chinese medicines It has also developed and sells "BU HEALTH" products to contribute to the health and well-being of the community.
SCM frequently organises large-scale international academic conferences in collaboration with academic and research institutes in the mainland and overseas to foster academic exchanges and collaborations in Chinese medicine. Committed to the standardisation and internationalisation of Chinese medicine, we participate in work pertaining to the standardisation of Chinese medicine undertaken by the World Health Organisation and the International Organisation for Standardisation and the formulation of two sets of national Chinese medicines coding and the Chinese medicine clinical practice guideline for three common diseases in Hong Kong. We have also rendered assistance to the Department of Health of HKSAR in formulating the Hong Kong Chinese Materia Medica Standard.
SCM has been offering first-rate Chinese medicine healthcare services since 1999 and now operates a total of sixteen clinics all over the territory－nine operated directly by SCM and seven established in collaboration with Hospital Authority and non-profit making organisations. Our healthcare service enjoys a high degree of popularity in the community, with patient attendance at the clinics operated directly by SCM exceeding 1.82 million over the years. Apart from serving the community, our Chinese medicine experts conduct clinical observations, and their study results expound the effectiveness of Chinese medicine by way of evidence-based medicine.